Crowdonomics
This isn’t AEXLAB’s most recent raise. Reg CF · Class A Common Stock · Mar 2025 (Closed) is more current.View latest round
AEXLAB

Reg CF · Common Stock · Nov 2024

ClosedReached targetReg CFCommon Equity
via DealMaker · last checked Sep 28, 2026
Raised
$59.7K / $5M max
1% of ceiling
Investors
21
$2.8K avg
Post-money valuation
$108.3M
pre-money + amount raised

Financials disclosed in this offering

FY2022–FY2023 · hover for source
$185K
−$3.3M
FY2022
$234K
−$3.7M
FY2023
RevenueNet income
Metric
FY2022 audited
FY2023 audited
Income statement
Revenue
$185,017
$234,201
Cost of goods sold
$0
$4,700,247
Gross margin
100%
-1907%
Net income
-$3,331,229
-$3,675,269
Taxes paid
$0
$0
Balance sheet
Cash
$3,574,847
$1,708,830
Accounts receivable
$42,699
$276,087
Total assets
$10,235,097
$10,539,228
Short-term debt
$0
$686,778
Long-term debt
$4,175,000
$8,061,901
Total liabilities
$4,175,000
$8,748,679
Other
Headcount
13
10

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Amendments to this offering

1 amendment
  1. Sep 24, 2025
    • Deadline Nov 24, 2025 → Feb 2, 2026
    • Maximum $5M → $4.9M
    • Security Common Stock → Other: Class A Common Stock

    “Extend offering end date to February 2, 2026, Add Board Member titles to Jonathan Ovadia and Albert Ovadia for clarification”

    Form C/A on EDGAR ↗

Each line compares the amendment with the previous filing of this offering. The quoted reason is the issuer’s own statement from the Form C/A.

Deal terms

Pre-money$108.2M
Post-money$108.3M
Price / share$36.52
Shares offered132,281

Offering details

Target$10,017
Max$4,999,984
Min investment—
OpenedNov 25, 2024
DeadlineNov 24, 2025
ClosedNov 24, 2025
Days active364

Links & provenance

Source: SEC EDGAR
0001644600-24-000115
Last synced Sep 28, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.